"Dibenzothiazepines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D003987
|
MeSH Number(s) |
D02.886.680.702.500 D03.633.300.276
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dibenzothiazepines".
Below are MeSH descriptors whose meaning is more specific than "Dibenzothiazepines".
This graph shows the total number of publications written about "Dibenzothiazepines" by people in this website by year, and whether "Dibenzothiazepines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
2003 | 1 | 1 | 2 |
2004 | 2 | 0 | 2 |
2005 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2007 | 2 | 0 | 2 |
2010 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dibenzothiazepines" by people in Profiles.
-
Ittasakul P, Johnson KR, Srivastava S, Childers ME, Brooks JO, Hoblyn JC, Ketter TA. Effectiveness of quetiapine plus lamotrigine maintenance therapy in challenging bipolar disorder patients. J Affect Disord. 2012 Mar; 137(1-3):139-45.
-
Katzman MA, Brawman-Mintzer O, Reyes EB, Olausson B, Liu S, Eriksson H. Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trial. Int Clin Psychopharmacol. 2011 Jan; 26(1):11-24.
-
Ketter TA, Brooks JO, Hoblyn JC, Holland AA, Nam JY, Culver JL, Marsh WK, Bonner JC. Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting. J Psychiatr Res. 2010 Oct; 44(14):921-9.
-
Wright TM, Vandenberg AM. Risperidone- and quetiapine-induced cholestasis. Ann Pharmacother. 2007 Sep; 41(9):1518-23.
-
Zhong KX, Tariot PN, Mintzer J, Minkwitz MC, Devine NA. Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study. Curr Alzheimer Res. 2007 Feb; 4(1):81-93.
-
Tariot PN, Schneider L, Katz IR, Mintzer JE, Street J, Copenhaver M, Williams-Hughes C. Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial. Am J Geriatr Psychiatry. 2006 Sep; 14(9):767-76.
-
Robert S, Hamner MB, Kose S, Ulmer HG, Deitsch SE, Lorberbaum JP. Quetiapine improves sleep disturbances in combat veterans with PTSD: sleep data from a prospective, open-label study. J Clin Psychopharmacol. 2005 Aug; 25(4):387-8.
-
El Hajj I, Sharara AI, Rockey DC. Subfulminant liver failure associated with quetiapine. Eur J Gastroenterol Hepatol. 2004 Nov; 16(12):1415-8.
-
Mintzer JE, Mullen JA, Sweitzer DE. A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone. Curr Med Res Opin. 2004 Sep; 20(9):1483-91.
-
Motsinger CD, Perron GA, Lacy TJ. Use of atypical antipsychotic drugs in patients with dementia. Am Fam Physician. 2003 Jun 01; 67(11):2335-40.